Cashu FinanceCashu Finance
  • Terminal
  • Spotlight
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. PODD

Market Cap: $10.2B

IC

Insulet Corp.

PODD
NASDAQUSD
Purchase PODD
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

$147.23
-$1.78(-1.20%)
At close: Oct 26, 14:25 EDT

Recently from Cashu

Insulet Corp Faces Legal and Innovation Challenges

Insulet Corp Faces Legal and Innovation Challenges

Insulet Corp. PODD is at a critical intersection of groundbreaking product innovation and significant legal challenges that threaten its operational integrity and investor confidence. As the company s…

Cashu Finance·2 months ago
Insulet Corp: Navigating Innovation and Legal Hurdles

Insulet Corp: Navigating Innovation and Legal Hurdles

Insulet Corp. ( PODD ) is currently facing a pivotal moment in its corporate journey, defined by significant innovations in diabetes management as well as mounting legal challenges that could impact i…

Cashu Finance·2 months ago
Insulet Corp: Innovation Meets Legal Challenges

Insulet Corp: Innovation Meets Legal Challenges

Insulet Corp. PODD sits at a pivotal crossroads amid groundbreaking innovations in diabetes management and significant legal hurdles that threaten its operational integrity. The recent launch of the O…

Cashu Finance·2 months ago
Insulet Corp: Innovations and Legal Battles

Insulet Corp: Innovations and Legal Battles

Insulet Corp. ( PODD ) is currently navigating a complex landscape characterized by innovative advancements in diabetes management and serious legal challenges that threaten its operational integrity…

Cashu Finance·2 months ago

Open

$163.70

Prev. Close

$148.12

High

$164.40

Low

$158.72

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

CEOAshley McEvoy
SectorHealthcare
IndustryMedical - Devices
Employees5.4K
IPO DateMay 15, 2007
ExchangeNASDAQ
Exchange NameNASDAQ
CurrencyUSD
Headquarters & Contact
Address100 Nagog Park
City / State / ZIPActon, MA, 01720
CountryUnited States
Phone978 600 7000
Websitehttps://www.insulet.com